Avance Biosciences is pleased to announce its participation in the upcoming ASGCT 2025 Conference, taking place from May 13–17, 2025, in New Orleans, LA. This premier event will bring together leaders and innovators in the gene therapy and cell therapy space to explore the latest advancements and challenges in the field. With a focus on cutting-edge research, clinical developments, and therapeutic breakthroughs, ASGCT 2025 is set to be an exceptional opportunity for collaboration and knowledge-sharing.
Avance Biosciences: Pioneering Bioanalytical Solutions for Gene and Cell Therapy
At Avance Biosciences, we are committed to advancing the development of gene and cell therapies through our comprehensive bioanalytical services. As a trusted partner in drug discovery and development, we specialize in providing precise, reliable data for a wide range of therapeutic approaches, including gene therapies, cell therapies, and biologic characterization assays. With expertise in bioanalytical testing and a focus on emerging technologies, we support the successful progression of therapeutic candidates from preclinical stages through clinical trials.
Our Key Services Include:
-
Gene and Cell Therapy Bioanalysis: Leveraging advanced techniques like LBA (Ligand Binding Assays), Flow Cytometry, and PCR technologies (qPCR, ddPCR) to deliver highly accurate data for gene and cell therapy programs.
-
Advanced Analytical Technologies: Utilizing next-generation sequencing (NGS), LC-MS/MS, and Hybrid LBA/LC-MS methods for precise and reproducible analysis across a broad range of biological samples.
-
Custom Solutions for Emerging Modalities: Providing tailored bioanalytical solutions for the most innovative therapies, including nucleic acid-based therapies, CAR T-cell therapies, and gene-editing approaches.
We’re thrilled to participate in ASGCT 2025, where we’ll showcase our advanced bioanalytical services supporting gene and cell therapy advancements. This conference is an exciting platform for us to collaborate with industry leaders, share our expertise, and discuss the future of gene and cell therapy. At Avance, we’re dedicated to providing the critical insights that support the success of these transformative therapies.”
Chris Hebel – VP of Marketing at Avance Biosciences.
We look forward to connecting with researchers, scientists, and industry leaders at this exciting event! Stop by booth #750 during ASGCT 2025 to explore our latest bioanalytical solutions and discover how Avance Biosciences can support your success in advancing gene and cell therapies. We look forward to meeting you!
Whether you are developing complex Biologics, Cell and Gene therapies, or other Advanced Therapeutics, Avance Biosciences is your trusted partner in delivering exceptional bioanalytical services that support your success at every stage of the drug development process. Contact our technical staff to discuss how we can support you in your project!
